Insight Report 5 minutes PremiumCoronavirus Insights: US Drugstores Step Up; Potential Drug Shortages Could Be a Long-Term Concern Coresight Research March 23, 2020 What's InsideWith the coronavirus continuing to spread globally, we consider its impact in the US drugstore sector. CVS, Rite Aid and Walgreens are adapting their services in response to the shifting landscape. We discuss the initiatives that these major drugstore chains in the US are rolling out to support consumers during the outbreak, including waiving fees and offering innovative, minimal-contact testing services. We also consider the potential challenge of drug shortages in the US over the longer term, due to the nation’s reliance on China in the medicine manufacturing supply chain. Click here to view Coresight Research’s ongoing coverage of the coronavirus outbreak. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Three Data Points We’re Watching This Week, Week 51: US Holiday Retail HomestretchNovember 2023 Leading Indicators of US Retail Sales: Projecting Low-Single-Digit Growth for the New YearJCPenney Merges with SPARC Group to Form Catalyst Brands—What It Means for US RetailEarnings Insights 2Q23, Week 3: Alibaba Reports Double-Digit Growth; Capri Holdings, Hanesbrands, Qurate Retail and Under Armour See Sales Decline